Disease-modifying Multiple Sclerosis Therapies Market Growth, Key Players, SWOT, Revenue Analysis Analysis By FMI
The global disease-modifying MS therapies market is poised for sustained growth, projected to expand from USD 31,915.8 million in 2026 to USD 63,372.5 million by 2036, registering a CAGR of 7.1% over the forecast period, according to Future Market Insights (FMI). Growth is being driven by a structural shift toward long-term disease modification, earlier treatment initiation, and...
0 Commenti 0 condivisioni 5 Views 0 Anteprima